Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Your GP or diabetes specialist can assess whether the symptoms are related to the medication and determine the most appropriate course of action
The Phase 2 obesity trial (Jastreboff et al., NEJM 2023) reported substantial reductions in body weight, with some participants achieving losses exceeding 20% of their baseline body weight at the highest doses studied
As the body ages, natural levels of GHK-Cu decline significantly, which is linked to slower healing and visible signs of ageing such as wrinkles and loss of elasticity
Menopausal lipid shifts and the loss of estrogen regulation create a unique vulnerability in women, which could intersect with the anti-inflammatory and lipid-modulating effects of GLP-1 therapies
US$ 25.88
US$ 29.06
US$ 21.64
US$ 26.66
US$ 23.42
US$ 29.78
